Materialise NV (MTLS)

$10.7

-0.09 (-0.83%)
Rating:
Recommendation:
Buy
Symbol MTLS
Price $10.7
Beta 0.759
Volume Avg. 0.17M
Market Cap 631.979M
Shares () -
52 Week Range 10.58-27.55
1y Target Est -
DCF Unlevered MTLS DCF ->
DCF Levered MTLS LDCF ->
ROE 6.22% Neutral
ROA 3.44% Neutral
Operating Margin -
Debt / Equity 78.70% Buy
P/E 42.80 Strong Buy
P/B 2.29 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest MTLS news


Mr. Wilfried Vancraen
Technology
Software—Application
NASDAQ Global Select

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.